Placebo to NT201 clinical trials

A prospective, randomized, double-blind, placebo-controlled, two-stage, multicenter study with an open-label extension period to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity in children and adolescents with cerebral palsy

This study is testing a medicine called NT 201 (also known as Xeomin) for children and teenagers with cerebral palsy who have stiff leg muscles. It aims to see if the medicine helps reduce the stiffness and improve movement, compared to a dummy treatment.